title: Capsule commentary on Romanelli et al., predictors of statin compliance after switching from branded to generic agents among managed-care beneficiaries.
authors.affiliation: Department of Cardiology, Prairie Heart Institute, Springfield, IL, USA, hpathak@prairieheart.com.
authors.forename: Himanshu
authors.initials: H
authors.lastname: Pathak
mesh_terms: D057915:Drug Substitution / Q000639:trends*; D016568:Drugs, Generic / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D008297:Male; D008329:Managed Care Programs / Q000639:trends*; D055118:Medication Adherence / Q000208:ethnology*
chemical_list: D016568:Drugs, Generic; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
references.citation: Yale J Health Policy Law Ethics. 2001 Spring;1:15-32
references.pmid: 12669319
references.citation: J Gen Intern Med. 2014 Oct;29(10):1372-8
references.pmid: 24957381